Trial intelligence / Profile preview

Prospective randomized study of loperamide vs tincture of opium for therapy-associated diarrhea during pelvic radiotherapy

2006-002948-28Phase 3Terminated

Sponsor
MAROS Arzneimittel
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in diarrhea and radiation enteritis comparing Imodium (loperamide) with Tincture of opium (2 arms). Primary endpoint: Prevention of grade >2 diarrhea. Started Aug 2006; status: terminated.

02

Drugs

loperamideopium
03

Conditions

diarrhearadiation enteritis

Beyond the preview

Go deeper on 2006-002948-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002948-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call